nodes	percent_of_prediction	percent_of_DWPC	metapath
Bleomycin—hematologic cancer—muscle cancer	0.383	0.456	CtDrD
Bleomycin—testicular cancer—muscle cancer	0.233	0.278	CtDrD
Bleomycin—germ cell cancer—muscle cancer	0.223	0.266	CtDrD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)—PMS2—muscle cancer	0.00954	0.189	CbGpPWpGaD
Bleomycin—LIG1—Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)—PMS2—muscle cancer	0.00954	0.189	CbGpPWpGaD
Bleomycin—LIG1—MMR—PMS2—muscle cancer	0.00906	0.179	CbGpPWpGaD
Bleomycin—LIG1—Early Phase of HIV Life Cycle—HMGA1—muscle cancer	0.00579	0.115	CbGpPWpGaD
Bleomycin—LIG1—embryo—muscle cancer	0.00491	0.12	CbGeAlD
Bleomycin—LIG3—DNA Repair—PMS2—muscle cancer	0.00489	0.0967	CbGpPWpGaD
Bleomycin—LIG3—renal system—muscle cancer	0.00402	0.0979	CbGeAlD
Bleomycin—Nail changes—Etoposide—muscle cancer	0.00325	0.0499	CcSEcCtD
Bleomycin—BLMH—renal system—muscle cancer	0.003	0.0732	CbGeAlD
Bleomycin—LIG1—bone marrow—muscle cancer	0.00281	0.0685	CbGeAlD
Bleomycin—LIG1—vagina—muscle cancer	0.00269	0.0656	CbGeAlD
Bleomycin—BLMH—cardiac atrium—muscle cancer	0.00269	0.0655	CbGeAlD
Bleomycin—LIG3—head—muscle cancer	0.00269	0.0655	CbGeAlD
Bleomycin—LIG3—testis—muscle cancer	0.0026	0.0633	CbGeAlD
Bleomycin—LIG1—head—muscle cancer	0.00249	0.0606	CbGeAlD
Bleomycin—Lung fibrosis interstitial—Methotrexate—muscle cancer	0.00245	0.0376	CcSEcCtD
Bleomycin—LIG1—testis—muscle cancer	0.0024	0.0586	CbGeAlD
Bleomycin—BLMH—tendon—muscle cancer	0.00234	0.0571	CbGeAlD
Bleomycin—BLMH—bone marrow—muscle cancer	0.00227	0.0553	CbGeAlD
Bleomycin—BLMH—vagina—muscle cancer	0.00217	0.053	CbGeAlD
Bleomycin—BLMH—head—muscle cancer	0.00201	0.049	CbGeAlD
Bleomycin—Nail changes—Methotrexate—muscle cancer	0.00195	0.0299	CcSEcCtD
Bleomycin—BLMH—testis—muscle cancer	0.00194	0.0473	CbGeAlD
Bleomycin—LIG1—DNA Repair—PMS2—muscle cancer	0.0019	0.0375	CbGpPWpGaD
Bleomycin—Dry cough—Methotrexate—muscle cancer	0.00183	0.028	CcSEcCtD
Bleomycin—LIG1—Vindesine—Vincristine—muscle cancer	0.00176	0.484	CbGdCrCtD
Bleomycin—Myelosuppression—Dactinomycin—muscle cancer	0.00139	0.0213	CcSEcCtD
Bleomycin—Myelosuppression—Vincristine—muscle cancer	0.00124	0.0191	CcSEcCtD
Bleomycin—Cystitis haemorrhagic—Doxorubicin—muscle cancer	0.00122	0.0187	CcSEcCtD
Bleomycin—LIG1—Podofilox—Etoposide—muscle cancer	0.00111	0.305	CbGdCrCtD
Bleomycin—Febrile neutropenia—Dactinomycin—muscle cancer	0.00108	0.0166	CcSEcCtD
Bleomycin—Pulmonary fibrosis—Etoposide—muscle cancer	0.00107	0.0165	CcSEcCtD
Bleomycin—Induration—Etoposide—muscle cancer	0.00106	0.0162	CcSEcCtD
Bleomycin—Myelosuppression—Etoposide—muscle cancer	0.00101	0.0154	CcSEcCtD
Bleomycin—Febrile neutropenia—Vincristine—muscle cancer	0.000968	0.0149	CcSEcCtD
Bleomycin—LIG1—HIV Life Cycle—HMGA1—muscle cancer	0.000939	0.0186	CbGpPWpGaD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000878	0.0174	CbGpPWpGaD
Bleomycin—BLMH—Adaptive Immune System—CD34—muscle cancer	0.00086	0.017	CbGpPWpGaD
Bleomycin—Mucosal inflammation—Etoposide—muscle cancer	0.000852	0.0131	CcSEcCtD
Bleomycin—Nephropathy toxic—Etoposide—muscle cancer	0.000822	0.0126	CcSEcCtD
Bleomycin—Febrile neutropenia—Etoposide—muscle cancer	0.000785	0.012	CcSEcCtD
Bleomycin—LIG1—Vinblastine—Vincristine—muscle cancer	0.000762	0.21	CbGdCrCtD
Bleomycin—Extravasation—Dactinomycin—muscle cancer	0.000747	0.0115	CcSEcCtD
Bleomycin—Nail disorder—Etoposide—muscle cancer	0.000728	0.0112	CcSEcCtD
Bleomycin—Ulcer—Dactinomycin—muscle cancer	0.000689	0.0106	CcSEcCtD
Bleomycin—Rales—Methotrexate—muscle cancer	0.000689	0.0106	CcSEcCtD
Bleomycin—Extravasation—Vincristine—muscle cancer	0.000668	0.0102	CcSEcCtD
Bleomycin—Interstitial lung disease—Etoposide—muscle cancer	0.000667	0.0102	CcSEcCtD
Bleomycin—LIG1—HIV Infection—HMGA1—muscle cancer	0.000649	0.0128	CbGpPWpGaD
Bleomycin—Pulmonary fibrosis—Methotrexate—muscle cancer	0.000643	0.00986	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000642	0.0127	CbGpPWpGaD
Bleomycin—Lung infiltration—Methotrexate—muscle cancer	0.000603	0.00925	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—FOXO4—muscle cancer	0.000585	0.0116	CbGpPWpGaD
Bleomycin—Phlebitis—Dactinomycin—muscle cancer	0.000549	0.00843	CcSEcCtD
Bleomycin—Extravasation—Etoposide—muscle cancer	0.000541	0.0083	CcSEcCtD
Bleomycin—Myelosuppression—Doxorubicin—muscle cancer	0.000522	0.00801	CcSEcCtD
Bleomycin—BLMH—Immune System—CD34—muscle cancer	0.000522	0.0103	CbGpPWpGaD
Bleomycin—Mucosal inflammation—Methotrexate—muscle cancer	0.000511	0.00784	CcSEcCtD
Bleomycin—Ulcer—Etoposide—muscle cancer	0.000499	0.00766	CcSEcCtD
Bleomycin—Skin hyperpigmentation—Methotrexate—muscle cancer	0.000475	0.00729	CcSEcCtD
Bleomycin—Febrile neutropenia—Methotrexate—muscle cancer	0.00047	0.00721	CcSEcCtD
Bleomycin—Skin exfoliation—Etoposide—muscle cancer	0.000451	0.00692	CcSEcCtD
Bleomycin—Mucosal inflammation—Doxorubicin—muscle cancer	0.000442	0.00679	CcSEcCtD
Bleomycin—Local reaction—Doxorubicin—muscle cancer	0.000442	0.00679	CcSEcCtD
Bleomycin—Nail disorder—Methotrexate—muscle cancer	0.000436	0.00669	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—FOXO1—muscle cancer	0.000432	0.00854	CbGpPWpGaD
Bleomycin—Skin hyperpigmentation—Doxorubicin—muscle cancer	0.000412	0.00632	CcSEcCtD
Bleomycin—Febrile neutropenia—Doxorubicin—muscle cancer	0.000407	0.00625	CcSEcCtD
Bleomycin—Interstitial lung disease—Methotrexate—muscle cancer	0.000399	0.00613	CcSEcCtD
Bleomycin—Phlebitis—Etoposide—muscle cancer	0.000398	0.0061	CcSEcCtD
Bleomycin—Pancytopenia—Dactinomycin—muscle cancer	0.000389	0.00596	CcSEcCtD
Bleomycin—Hypomagnesaemia—Doxorubicin—muscle cancer	0.000385	0.00591	CcSEcCtD
Bleomycin—Nail disorder—Doxorubicin—muscle cancer	0.000377	0.00579	CcSEcCtD
Bleomycin—Pneumonia—Dactinomycin—muscle cancer	0.000367	0.00563	CcSEcCtD
Bleomycin—Stomatitis—Dactinomycin—muscle cancer	0.000356	0.00546	CcSEcCtD
Bleomycin—BLMH—Immune System—FOXO4—muscle cancer	0.000355	0.00702	CbGpPWpGaD
Bleomycin—Pancytopenia—Vincristine—muscle cancer	0.000347	0.00533	CcSEcCtD
Bleomycin—Weight decreased—Vincristine—muscle cancer	0.000331	0.00508	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—KIT—muscle cancer	0.000329	0.00651	CbGpPWpGaD
Bleomycin—Pneumonia—Vincristine—muscle cancer	0.000328	0.00503	CcSEcCtD
Bleomycin—Extravasation—Methotrexate—muscle cancer	0.000324	0.00497	CcSEcCtD
Bleomycin—Acute coronary syndrome—Vincristine—muscle cancer	0.000321	0.00493	CcSEcCtD
Bleomycin—Myocardial infarction—Vincristine—muscle cancer	0.000319	0.0049	CcSEcCtD
Bleomycin—Stomatitis—Vincristine—muscle cancer	0.000318	0.00488	CcSEcCtD
Bleomycin—Hyperaesthesia—Doxorubicin—muscle cancer	0.000312	0.00479	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—BUB1B—muscle cancer	0.000311	0.00615	CbGpPWpGaD
Bleomycin—Flushing—Dactinomycin—muscle cancer	0.000304	0.00466	CcSEcCtD
Bleomycin—Ulcer—Methotrexate—muscle cancer	0.000299	0.00459	CcSEcCtD
Bleomycin—Chills—Dactinomycin—muscle cancer	0.000294	0.00451	CcSEcCtD
Bleomycin—Bronchospasm—Etoposide—muscle cancer	0.000291	0.00447	CcSEcCtD
Bleomycin—Hypoaesthesia—Vincristine—muscle cancer	0.000291	0.00447	CcSEcCtD
Bleomycin—Alopecia—Dactinomycin—muscle cancer	0.000289	0.00444	CcSEcCtD
Bleomycin—Erythema—Dactinomycin—muscle cancer	0.000285	0.00438	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000285	0.00563	CbGpPWpGaD
Bleomycin—Pancytopenia—Etoposide—muscle cancer	0.000281	0.00432	CcSEcCtD
Bleomycin—Extravasation—Doxorubicin—muscle cancer	0.000281	0.00431	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—BUB1B—muscle cancer	0.000278	0.0055	CbGpPWpGaD
Bleomycin—Cystitis noninfective—Methotrexate—muscle cancer	0.000276	0.00424	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000274	0.00542	CbGpPWpGaD
Bleomycin—Cystitis—Methotrexate—muscle cancer	0.000273	0.00419	CcSEcCtD
Bleomycin—Skin exfoliation—Methotrexate—muscle cancer	0.00027	0.00414	CcSEcCtD
Bleomycin—Pneumonia—Etoposide—muscle cancer	0.000266	0.00408	CcSEcCtD
Bleomycin—Ill-defined disorder—Dactinomycin—muscle cancer	0.000264	0.00406	CcSEcCtD
Bleomycin—Anaemia—Dactinomycin—muscle cancer	0.000263	0.00404	CcSEcCtD
Bleomycin—BLMH—Immune System—FOXO1—muscle cancer	0.000262	0.00518	CbGpPWpGaD
Bleomycin—Acute coronary syndrome—Etoposide—muscle cancer	0.00026	0.00399	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—MDM2—muscle cancer	0.000259	0.00513	CbGpPWpGaD
Bleomycin—Ulcer—Doxorubicin—muscle cancer	0.000259	0.00397	CcSEcCtD
Bleomycin—Myocardial infarction—Etoposide—muscle cancer	0.000259	0.00397	CcSEcCtD
Bleomycin—Alopecia—Vincristine—muscle cancer	0.000259	0.00397	CcSEcCtD
Bleomycin—Stomatitis—Etoposide—muscle cancer	0.000257	0.00395	CcSEcCtD
Bleomycin—Malaise—Dactinomycin—muscle cancer	0.000257	0.00395	CcSEcCtD
Bleomycin—Bladder pain—Methotrexate—muscle cancer	0.000256	0.00392	CcSEcCtD
Bleomycin—Leukopenia—Dactinomycin—muscle cancer	0.000255	0.00392	CcSEcCtD
Bleomycin—Myalgia—Dactinomycin—muscle cancer	0.000243	0.00372	CcSEcCtD
Bleomycin—Discomfort—Dactinomycin—muscle cancer	0.00024	0.00368	CcSEcCtD
Bleomycin—Cystitis noninfective—Doxorubicin—muscle cancer	0.000239	0.00367	CcSEcCtD
Bleomycin—Cystitis—Doxorubicin—muscle cancer	0.000236	0.00363	CcSEcCtD
Bleomycin—Hypoaesthesia—Etoposide—muscle cancer	0.000236	0.00362	CcSEcCtD
Bleomycin—Anaemia—Vincristine—muscle cancer	0.000235	0.00361	CcSEcCtD
Bleomycin—Skin exfoliation—Doxorubicin—muscle cancer	0.000234	0.00359	CcSEcCtD
Bleomycin—Oedema—Dactinomycin—muscle cancer	0.000233	0.00357	CcSEcCtD
Bleomycin—Infection—Dactinomycin—muscle cancer	0.000231	0.00355	CcSEcCtD
Bleomycin—Leukopenia—Vincristine—muscle cancer	0.000228	0.0035	CcSEcCtD
Bleomycin—Thrombocytopenia—Dactinomycin—muscle cancer	0.000228	0.0035	CcSEcCtD
Bleomycin—Anorexia—Dactinomycin—muscle cancer	0.000222	0.0034	CcSEcCtD
Bleomycin—Bladder pain—Doxorubicin—muscle cancer	0.000221	0.0034	CcSEcCtD
Bleomycin—Flushing—Etoposide—muscle cancer	0.00022	0.00338	CcSEcCtD
Bleomycin—Myalgia—Vincristine—muscle cancer	0.000217	0.00333	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000216	0.00427	CbGpPWpGaD
Bleomycin—Chills—Etoposide—muscle cancer	0.000213	0.00326	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000212	0.00325	CcSEcCtD
Bleomycin—Alopecia—Etoposide—muscle cancer	0.000209	0.00321	CcSEcCtD
Bleomycin—Cerebrovascular accident—Methotrexate—muscle cancer	0.000209	0.00321	CcSEcCtD
Bleomycin—Anaphylactic shock—Vincristine—muscle cancer	0.000208	0.00319	CcSEcCtD
Bleomycin—Oedema—Vincristine—muscle cancer	0.000208	0.00319	CcSEcCtD
Bleomycin—Infection—Vincristine—muscle cancer	0.000207	0.00317	CcSEcCtD
Bleomycin—Phlebitis—Doxorubicin—muscle cancer	0.000206	0.00317	CcSEcCtD
Bleomycin—Thrombocytopenia—Vincristine—muscle cancer	0.000204	0.00312	CcSEcCtD
Bleomycin—Decreased appetite—Dactinomycin—muscle cancer	0.000202	0.0031	CcSEcCtD
Bleomycin—BLMH—Immune System—KIT—muscle cancer	0.0002	0.00395	CbGpPWpGaD
Bleomycin—Pain—Dactinomycin—muscle cancer	0.000199	0.00305	CcSEcCtD
Bleomycin—Anorexia—Vincristine—muscle cancer	0.000198	0.00304	CcSEcCtD
Bleomycin—Hypotension—Vincristine—muscle cancer	0.000194	0.00298	CcSEcCtD
Bleomycin—Feeling abnormal—Dactinomycin—muscle cancer	0.000192	0.00294	CcSEcCtD
Bleomycin—Ill-defined disorder—Etoposide—muscle cancer	0.000191	0.00294	CcSEcCtD
Bleomycin—Anaemia—Etoposide—muscle cancer	0.000191	0.00293	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000189	0.00291	CcSEcCtD
Bleomycin—Paraesthesia—Vincristine—muscle cancer	0.000187	0.00286	CcSEcCtD
Bleomycin—Malaise—Etoposide—muscle cancer	0.000186	0.00286	CcSEcCtD
Bleomycin—Leukopenia—Etoposide—muscle cancer	0.000185	0.00283	CcSEcCtD
Bleomycin—Body temperature increased—Dactinomycin—muscle cancer	0.000184	0.00282	CcSEcCtD
Bleomycin—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000181	0.00278	CcSEcCtD
Bleomycin—Decreased appetite—Vincristine—muscle cancer	0.000181	0.00277	CcSEcCtD
Bleomycin—Cough—Etoposide—muscle cancer	0.00018	0.00276	CcSEcCtD
Bleomycin—Pain—Vincristine—muscle cancer	0.000178	0.00273	CcSEcCtD
Bleomycin—Chest pain—Etoposide—muscle cancer	0.000176	0.0027	CcSEcCtD
Bleomycin—LIG1—Disease—ENO2—muscle cancer	0.000175	0.00346	CbGpPWpGaD
Bleomycin—Discomfort—Etoposide—muscle cancer	0.000174	0.00266	CcSEcCtD
Bleomycin—Hypersensitivity—Dactinomycin—muscle cancer	0.000171	0.00263	CcSEcCtD
Bleomycin—Confusional state—Etoposide—muscle cancer	0.00017	0.00261	CcSEcCtD
Bleomycin—Pancytopenia—Methotrexate—muscle cancer	0.000168	0.00259	CcSEcCtD
Bleomycin—Anaphylactic shock—Etoposide—muscle cancer	0.000168	0.00258	CcSEcCtD
Bleomycin—Infection—Etoposide—muscle cancer	0.000167	0.00257	CcSEcCtD
Bleomycin—Asthenia—Dactinomycin—muscle cancer	0.000167	0.00256	CcSEcCtD
Bleomycin—Thrombocytopenia—Etoposide—muscle cancer	0.000165	0.00253	CcSEcCtD
Bleomycin—Body temperature increased—Vincristine—muscle cancer	0.000164	0.00252	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000163	0.00323	CbGpPWpGaD
Bleomycin—Anorexia—Etoposide—muscle cancer	0.000161	0.00246	CcSEcCtD
Bleomycin—Pneumonia—Methotrexate—muscle cancer	0.000159	0.00244	CcSEcCtD
Bleomycin—LIG1—Disease—HMGA1—muscle cancer	0.000159	0.00314	CbGpPWpGaD
Bleomycin—Hypotension—Etoposide—muscle cancer	0.000157	0.00241	CcSEcCtD
Bleomycin—BLMH—Immune System—MDM2—muscle cancer	0.000157	0.00311	CbGpPWpGaD
Bleomycin—Stomatitis—Methotrexate—muscle cancer	0.000154	0.00237	CcSEcCtD
Bleomycin—Hypersensitivity—Vincristine—muscle cancer	0.000153	0.00235	CcSEcCtD
Bleomycin—Paraesthesia—Etoposide—muscle cancer	0.000151	0.00232	CcSEcCtD
Bleomycin—Haematuria—Methotrexate—muscle cancer	0.000151	0.00231	CcSEcCtD
Bleomycin—Dyspnoea—Etoposide—muscle cancer	0.00015	0.0023	CcSEcCtD
Bleomycin—Asthenia—Vincristine—muscle cancer	0.000149	0.00229	CcSEcCtD
Bleomycin—Vomiting—Dactinomycin—muscle cancer	0.000148	0.00227	CcSEcCtD
Bleomycin—Rash—Dactinomycin—muscle cancer	0.000147	0.00225	CcSEcCtD
Bleomycin—Decreased appetite—Etoposide—muscle cancer	0.000146	0.00225	CcSEcCtD
Bleomycin—Pancytopenia—Doxorubicin—muscle cancer	0.000146	0.00224	CcSEcCtD
Bleomycin—Pain—Etoposide—muscle cancer	0.000144	0.00221	CcSEcCtD
Bleomycin—Haemoglobin—Methotrexate—muscle cancer	0.000143	0.00219	CcSEcCtD
Bleomycin—LIG1—Disease—FOXO4—muscle cancer	0.000143	0.00282	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDKN2A—muscle cancer	0.000142	0.00281	CbGpPWpGaD
Bleomycin—Haemorrhage—Methotrexate—muscle cancer	0.000142	0.00218	CcSEcCtD
Bleomycin—Weight decreased—Doxorubicin—muscle cancer	0.000139	0.00213	CcSEcCtD
Bleomycin—Feeling abnormal—Etoposide—muscle cancer	0.000139	0.00213	CcSEcCtD
Bleomycin—Nausea—Dactinomycin—muscle cancer	0.000138	0.00212	CcSEcCtD
Bleomycin—Pneumonia—Doxorubicin—muscle cancer	0.000138	0.00211	CcSEcCtD
Bleomycin—Urticaria—Etoposide—muscle cancer	0.000134	0.00205	CcSEcCtD
Bleomycin—Stomatitis—Doxorubicin—muscle cancer	0.000133	0.00205	CcSEcCtD
Bleomycin—Body temperature increased—Etoposide—muscle cancer	0.000133	0.00204	CcSEcCtD
Bleomycin—Vomiting—Vincristine—muscle cancer	0.000132	0.00203	CcSEcCtD
Bleomycin—Rash—Vincristine—muscle cancer	0.000131	0.00201	CcSEcCtD
Bleomycin—Dermatitis—Vincristine—muscle cancer	0.000131	0.00201	CcSEcCtD
Bleomycin—Haematuria—Doxorubicin—muscle cancer	0.000131	0.002	CcSEcCtD
Bleomycin—Chills—Methotrexate—muscle cancer	0.000127	0.00196	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—CDKN2A—muscle cancer	0.000127	0.00251	CbGpPWpGaD
Bleomycin—Alopecia—Methotrexate—muscle cancer	0.000125	0.00193	CcSEcCtD
Bleomycin—Hypersensitivity—Etoposide—muscle cancer	0.000124	0.0019	CcSEcCtD
Bleomycin—Erythema—Methotrexate—muscle cancer	0.000124	0.0019	CcSEcCtD
Bleomycin—Haemoglobin—Doxorubicin—muscle cancer	0.000124	0.0019	CcSEcCtD
Bleomycin—Nausea—Vincristine—muscle cancer	0.000123	0.0019	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—MDM2—muscle cancer	0.000123	0.00244	CbGpPWpGaD
Bleomycin—Haemorrhage—Doxorubicin—muscle cancer	0.000123	0.00189	CcSEcCtD
Bleomycin—Hypoaesthesia—Doxorubicin—muscle cancer	0.000122	0.00188	CcSEcCtD
Bleomycin—Asthenia—Etoposide—muscle cancer	0.000121	0.00185	CcSEcCtD
Bleomycin—Pruritus—Etoposide—muscle cancer	0.000119	0.00183	CcSEcCtD
Bleomycin—Ill-defined disorder—Methotrexate—muscle cancer	0.000115	0.00176	CcSEcCtD
Bleomycin—Anaemia—Methotrexate—muscle cancer	0.000114	0.00175	CcSEcCtD
Bleomycin—Flushing—Doxorubicin—muscle cancer	0.000114	0.00175	CcSEcCtD
Bleomycin—Malaise—Methotrexate—muscle cancer	0.000111	0.00171	CcSEcCtD
Bleomycin—Leukopenia—Methotrexate—muscle cancer	0.000111	0.0017	CcSEcCtD
Bleomycin—Chills—Doxorubicin—muscle cancer	0.00011	0.00169	CcSEcCtD
Bleomycin—Alopecia—Doxorubicin—muscle cancer	0.000109	0.00167	CcSEcCtD
Bleomycin—Cough—Methotrexate—muscle cancer	0.000108	0.00166	CcSEcCtD
Bleomycin—Vomiting—Etoposide—muscle cancer	0.000107	0.00164	CcSEcCtD
Bleomycin—Erythema—Doxorubicin—muscle cancer	0.000107	0.00164	CcSEcCtD
Bleomycin—Rash—Etoposide—muscle cancer	0.000106	0.00163	CcSEcCtD
Bleomycin—Dermatitis—Etoposide—muscle cancer	0.000106	0.00163	CcSEcCtD
Bleomycin—LIG1—Disease—FOXO1—muscle cancer	0.000105	0.00208	CbGpPWpGaD
Bleomycin—Chest pain—Methotrexate—muscle cancer	0.000105	0.00161	CcSEcCtD
Bleomycin—Myalgia—Methotrexate—muscle cancer	0.000105	0.00161	CcSEcCtD
Bleomycin—Discomfort—Methotrexate—muscle cancer	0.000104	0.0016	CcSEcCtD
Bleomycin—Confusional state—Methotrexate—muscle cancer	0.000102	0.00156	CcSEcCtD
Bleomycin—Anaphylactic shock—Methotrexate—muscle cancer	0.000101	0.00155	CcSEcCtD
Bleomycin—Infection—Methotrexate—muscle cancer	0.0001	0.00154	CcSEcCtD
Bleomycin—Nausea—Etoposide—muscle cancer	0.0001	0.00154	CcSEcCtD
Bleomycin—Ill-defined disorder—Doxorubicin—muscle cancer	9.93e-05	0.00152	CcSEcCtD
Bleomycin—Anaemia—Doxorubicin—muscle cancer	9.89e-05	0.00152	CcSEcCtD
Bleomycin—Thrombocytopenia—Methotrexate—muscle cancer	9.88e-05	0.00152	CcSEcCtD
Bleomycin—Malaise—Doxorubicin—muscle cancer	9.65e-05	0.00148	CcSEcCtD
Bleomycin—Anorexia—Methotrexate—muscle cancer	9.61e-05	0.00148	CcSEcCtD
Bleomycin—Leukopenia—Doxorubicin—muscle cancer	9.58e-05	0.00147	CcSEcCtD
Bleomycin—Hypotension—Methotrexate—muscle cancer	9.42e-05	0.00145	CcSEcCtD
Bleomycin—Cough—Doxorubicin—muscle cancer	9.34e-05	0.00143	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Methotrexate—muscle cancer	9.19e-05	0.00141	CcSEcCtD
Bleomycin—Chest pain—Doxorubicin—muscle cancer	9.11e-05	0.0014	CcSEcCtD
Bleomycin—Myalgia—Doxorubicin—muscle cancer	9.11e-05	0.0014	CcSEcCtD
Bleomycin—Paraesthesia—Methotrexate—muscle cancer	9.06e-05	0.00139	CcSEcCtD
Bleomycin—Discomfort—Doxorubicin—muscle cancer	9e-05	0.00138	CcSEcCtD
Bleomycin—Dyspnoea—Methotrexate—muscle cancer	8.99e-05	0.00138	CcSEcCtD
Bleomycin—Confusional state—Doxorubicin—muscle cancer	8.81e-05	0.00135	CcSEcCtD
Bleomycin—Decreased appetite—Methotrexate—muscle cancer	8.77e-05	0.00135	CcSEcCtD
Bleomycin—Anaphylactic shock—Doxorubicin—muscle cancer	8.73e-05	0.00134	CcSEcCtD
Bleomycin—Oedema—Doxorubicin—muscle cancer	8.73e-05	0.00134	CcSEcCtD
Bleomycin—Infection—Doxorubicin—muscle cancer	8.68e-05	0.00133	CcSEcCtD
Bleomycin—Pain—Methotrexate—muscle cancer	8.62e-05	0.00132	CcSEcCtD
Bleomycin—Thrombocytopenia—Doxorubicin—muscle cancer	8.55e-05	0.00131	CcSEcCtD
Bleomycin—Anorexia—Doxorubicin—muscle cancer	8.32e-05	0.00128	CcSEcCtD
Bleomycin—Feeling abnormal—Methotrexate—muscle cancer	8.31e-05	0.00128	CcSEcCtD
Bleomycin—Hypotension—Doxorubicin—muscle cancer	8.16e-05	0.00125	CcSEcCtD
Bleomycin—LIG1—Disease—KIT—muscle cancer	8.02e-05	0.00159	CbGpPWpGaD
Bleomycin—Urticaria—Methotrexate—muscle cancer	8.01e-05	0.00123	CcSEcCtD
Bleomycin—Body temperature increased—Methotrexate—muscle cancer	7.97e-05	0.00122	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	7.96e-05	0.00122	CcSEcCtD
Bleomycin—Paraesthesia—Doxorubicin—muscle cancer	7.84e-05	0.0012	CcSEcCtD
Bleomycin—Dyspnoea—Doxorubicin—muscle cancer	7.79e-05	0.0012	CcSEcCtD
Bleomycin—Decreased appetite—Doxorubicin—muscle cancer	7.59e-05	0.00117	CcSEcCtD
Bleomycin—Pain—Doxorubicin—muscle cancer	7.47e-05	0.00115	CcSEcCtD
Bleomycin—Hypersensitivity—Methotrexate—muscle cancer	7.43e-05	0.00114	CcSEcCtD
Bleomycin—Asthenia—Methotrexate—muscle cancer	7.24e-05	0.00111	CcSEcCtD
Bleomycin—Feeling abnormal—Doxorubicin—muscle cancer	7.2e-05	0.0011	CcSEcCtD
Bleomycin—Pruritus—Methotrexate—muscle cancer	7.14e-05	0.0011	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—TP53—muscle cancer	7.07e-05	0.0014	CbGpPWpGaD
Bleomycin—Urticaria—Doxorubicin—muscle cancer	6.94e-05	0.00106	CcSEcCtD
Bleomycin—Body temperature increased—Doxorubicin—muscle cancer	6.9e-05	0.00106	CcSEcCtD
Bleomycin—Hypersensitivity—Doxorubicin—muscle cancer	6.43e-05	0.000988	CcSEcCtD
Bleomycin—Vomiting—Methotrexate—muscle cancer	6.41e-05	0.000984	CcSEcCtD
Bleomycin—Rash—Methotrexate—muscle cancer	6.36e-05	0.000976	CcSEcCtD
Bleomycin—Dermatitis—Methotrexate—muscle cancer	6.35e-05	0.000975	CcSEcCtD
Bleomycin—LIG1—Disease—MDM2—muscle cancer	6.32e-05	0.00125	CbGpPWpGaD
Bleomycin—Asthenia—Doxorubicin—muscle cancer	6.27e-05	0.000962	CcSEcCtD
Bleomycin—Pruritus—Doxorubicin—muscle cancer	6.18e-05	0.000948	CcSEcCtD
Bleomycin—LIG1—Disease—PTGS2—muscle cancer	6.09e-05	0.0012	CbGpPWpGaD
Bleomycin—Nausea—Methotrexate—muscle cancer	5.99e-05	0.000919	CcSEcCtD
Bleomycin—Vomiting—Doxorubicin—muscle cancer	5.55e-05	0.000852	CcSEcCtD
Bleomycin—Rash—Doxorubicin—muscle cancer	5.51e-05	0.000845	CcSEcCtD
Bleomycin—Dermatitis—Doxorubicin—muscle cancer	5.5e-05	0.000844	CcSEcCtD
Bleomycin—Nausea—Doxorubicin—muscle cancer	5.19e-05	0.000796	CcSEcCtD
